CG400549
/ CG Invites
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 30, 2023
A Review of Fatty Acid Biosynthesis Enzyme Inhibitors as Promising Antimicrobial Drugs.
(PubMed, Pharmaceuticals (Basel))
- "Furthermore, afabicin and CG400549, two promising compounds which also target FabI, are in clinical assays to treat Staphylococcus aureus...This review, after presenting the FAS-II system and its enzymes in Escherichia coli, highlights the reported inhibitors of the system. Their biological activities, main interactions formed with their targets and structure-activity relationships are presented as far as possible."
Journal • Review
1 to 1
Of
1
Go to page
1